Primary liver cancer: worldwide incidence and trends

F Xavier Bosch ¹, Josepa Ribes , Mireia Díaz

⁰Epidemiology and Cancer Registration Unit, IDIBELL Institut Català d'Oncologia, Avda. Gran Via s/n, Km 2.7. 08907 L'Hospitalet de Llobregat, Barcelona, Spain. x.bosch@ico.scs.es

Gastroenterology +

|

October 28, 2004

View abstract on PubMed

Summary

Liver cancer is a major global health concern, with over 564,000 new cases annually. Hepatitis B and C virus infections are the primary drivers, making prevention through vaccination and screening crucial.

Area Of Science

Hepatology
Oncology
Epidemiology

Background

Liver cancer is a significant global malignancy, ranking as the fifth most common cancer in men and eighth in women.
Incidence rates vary geographically and by age, with higher rates in men and increasing trends in developed nations due to past hepatitis B and C virus infections.

Purpose Of The Study

To summarize the global burden and epidemiological trends of liver cancer.
To highlight the role of hepatitis B and C viruses in liver cancer etiology and prevention.

Main Methods

Analysis of global cancer incidence estimates.
Review of epidemiological data on liver cancer and viral hepatitis.
Assessment of prevention strategies.

Main Results

Estimated 564,000 new liver cancer cases annually worldwide (398,000 men, 166,000 women).
Hepatitis B and C virus infections account for over 80% of liver cancer cases globally.
Incidence is increasing in developed countries due to historical viral infections, while decreasing in some areas due to hepatitis B vaccination.

Conclusions

Primary liver cancer is largely preventable through hepatitis B virus vaccination and screening for hepatitis B and C viruses.
Understanding the epidemiology and viral etiology is key to global liver cancer control efforts.

Related Concept Videos